🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOral semaglutide bioavailability optimization — 12 month update Page 12

Oral semaglutide bioavailability optimization — 12 month update

jim_asheville Wed, Feb 7, 2024 at 4:58 PM 58 replies 3,516 viewsPage 12 of 12
roxy_nash
Member
178
890
Dec 2024
Nashville, TN
May 13, 2024 at 11:43 AM#56
DataDave said:
If you are going to change something, change one thing and give it long enough to express itself.

That is right for the common case. Whether it is right for the case being asked about depends on a detail that has not been given.

Last edited: May 13, 2024 at 5:43 PM
46 21josh_phd_bmore, roxy_nash, tony_orlando and 43 others
Reply Quote Save Share Report
kate.chem
VIP Member
3,890
17,654
Dec 2023
California
May 16, 2024 at 1:20 AM#57
DataDave said:
If you are going to change something, change one thing and give it long enough to express itself.

This is exactly what I could not find anywhere else. Adding it to my notes with a link back to this thread.

45 20VanRx_Mike, steve_okc, dave_SLC and 42 others
Reply Quote Save Share Report
DeniseRN_TPA
Member
345
1,567
Aug 2024
Tampa, FL
May 18, 2024 at 2:58 PM#58

From the other side of the consultation, briefly. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

Last edited: May 18, 2024 at 5:58 PM
44 19tommy_boulder, hyun_seoul, jim_asheville and 41 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
tyler_CSCS
Member
567
2,567
Jun 2024
Phoenix, AZ
May 21, 2024 at 4:38 AM#59
DeniseRN_TPA said:
If two explanations both fit, the useful question is which one predicts something the other does not.

This is my experience too, for whatever a second data point is worth. Nothing to add that would improve it.

43 18amy_econ_NJ, bbq_ray_KC, oliver_london and 40 others
Reply Quote Save Share Report
RunnerRach
Member
467
2,123
Aug 2024
Boston, MA
May 23, 2024 at 6:19 PM#60
DeniseRN_TPA said:
If two explanations both fit, the useful question is which one predicts something the other does not.

Coming at DeniseRN_TPA’s question from a different direction. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

Last edited: May 23, 2024 at 9:19 PM
21 21tyler_CSCS, VanRx_Mike, steve_okc and 18 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register